Metabolic Syndrome

Genomic and Precision Medicine: Primary Care: Third Edition

Volumn , Issue , 2017, Pages 283-299

  Lanktree, Matthew B ^a   Hegele, Robert A ^b  

^a MCMASTER UNIVERSITY   (Canada)

^b UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

Atherosclerosis; Diabetes; Dyslipidemia; Genetics; Genome wide association studies; Hypertension; Insulin resistance; Lipodystrophy; Metabolic syndrome; Obesity

Indexed keywords

EID: 85054210328     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-12-800685-6.00015-1     Document Type: Chapter

References (50)

1. Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 2009, 120(16):1640-1645.
2. Ford ES, Giles WH, Dietz WH Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA 2002, 287(3):356-359.
3. Mente A, Yusuf S, Islam S, McQueen MJ, Tanomsup S, Onen CL, et al. Metabolic syndrome and risk of acute myocardial infarction a case-control study of 26,903 subjects from 52 countries. J Am Coll Cardiol 2010, 55(21):2390-2398.
4. Samuel VT, Petersen KF, Shulman GI Lipid-induced insulin resistance: unravelling the mechanism. Lancet. 2010, 375(9733):2267-2277.
5. Pollex RL, Hegele RA Genetic determinants of the metabolic syndrome. Nat Clin Pract Cardiovasc Med 2006, 3(9):482-489.
6. Cornier MA, Dabelea D, Hernandez TL, Lindstrom RC, Steig AJ, Stob NR, et al. The metabolic syndrome. Endocr Rev 2008, 29(7):777-822.
7. Mente A, Meyre D, Lanktree MB, Heydarpour M, Davis AD, Miller R, et al. Causal relationship between adiponectin and metabolic traits: a Mendelian randomization study in a multiethnic population. PLoS One 2013, 8(6):e66808.
8. Carmelli D, Cardon LR, Fabsitz R Clustering of hypertension, diabetes, and obesity in adult male twins: same genes or same environments?. Am J Hum Genet 1994, 55(3):566-573.
9. Sung J, Lee K, Song YM Heritabilities of the metabolic syndrome phenotypes and related factors in Korean twins. J Clin Endocrinol Metab 2009, 94(12):4946-4952.
10. Lin HF, Boden-Albala B, Juo SH, Park N, Rundek T, Sacco RL Heritabilities of the metabolic syndrome and its components in the Northern Manhattan Family Study. Diabetologia 2005, 48(10):2006-2012.
11. Bayoumi RA, Al-Yahyaee SA, Albarwani SA, Rizvi SG, Al-Hadabi S, Al-Ubaidi FF, et al. Heritability of determinants of the metabolic syndrome among healthy Arabs of the Oman family study. Obesity (Silver Spring) 2007, 15(3):551-556.
12. Khan RJ, Gebreab SY, Sims M, Riestra P, Xu R, Davis SK Prevalence, associated factors and heritabilities of metabolic syndrome and its individual components in African Americans: the Jackson Heart Study. BMJ Open 2015, 5(10):e008675.
13. Vattikuti S, Guo J, Chow CC Heritability and genetic correlations explained by common SNPs for metabolic syndrome traits. PLoS Genet 2012, 8(3):e1002637.
14. Moore SJ, Green JS, Fan Y, Bhogal AK, Dicks E, Fernandez BA, et al. Clinical and genetic epidemiology of Bardet-Biedl syndrome in Newfoundland: a 22-year prospective, population-based, cohort study. Am J Med Genet A 2005, 132(4):352-360.
15. Thauvin-Robinet C, Auclair M, Duplomb L, Caron-Debarle M, Avila M, St-Onge J, et al. PIK3R1 mutations cause syndromic insulin resistance with lipoatrophy. Am J Hum Genet 2013, 93(1):141-149.
16. Weedon MN, Ellard S, Prindle MJ, Caswell R, Lango Allen H, Oram R, et al. An in-frame deletion at the polymerase active site of POLD1 causes a multisystem disorder with lipodystrophy. Nat Genet 2013, 45(8):947-950.
17. Dyment DA, Smith AC, Alcantara D, Schwartzentruber JA, Basel-Vanagaite L, Curry CJ, et al. Mutations in PIK3R1 cause SHORT syndrome. Am J Hum Genet 2013, 93(1):158-166.
18. Payne F, Lim K, Girousse A, Brown RJ, Kory N, Robbins A, et al. Mutations disrupting the Kennedy phosphatidylcholine pathway in humans with congenital lipodystrophy and fatty liver disease. Proc Natl Acad Sci U S A 2014, 111(24):8901-8906.
19. Agarwal AK, Garg A A novel heterozygous mutation in peroxisome proliferator-activated receptor-gamma gene in a patient with familial partial lipodystrophy. J Clin Endocrinol Metab 2002, 87(1):408-411.
20. Hegele RA, Cao H, Frankowski C, Mathews ST, Leff T PPARG F388L, a transactivation-deficient mutant, in familial partial lipodystrophy. Diabetes 2002, 51(12):3586-3590.
21. Southam L, Soranzo N, Montgomery SB, Frayling TM, McCarthy MI, Barroso I, et al. Is the thrifty genotype hypothesis supported by evidence based on confirmed type 2 diabetes- and obesity-susceptibility variants?. Diabetologia 2009, 52(9):1846-1851.
22. Tan K, Pogozheva ID, Yeo GS, Hadaschik D, Keogh JM, Haskell-Leuvano C, et al. Functional characterization and structural modeling of obesity associated mutations in the melanocortin 4 receptor. Endocrinology. 2009, 150(1):114-125.
23. Farooqi IS, Keogh JM, Yeo GS, Lank EJ, Cheetham T, O'Rahilly S Clinical spectrum of obesity and mutations in the melanocortin 4 receptor gene. N Engl J Med 2003, 348(12):1085-1095.
24. Krude H, Biebermann H, Schnabel D, Tansek MZ, Theunissen P, Mullis PE, et al. Obesity due to proopiomelanocortin deficiency: three new cases and treatment trials with thyroid hormone and ACTH4-10. J Clin Endocrinol Metab 2003, 88(10):4633-4640.
25. Yaswen L, Diehl N, Brennan MB, Hochgeschwender U Obesity in the mouse model of pro-opiomelanocortin deficiency responds to peripheral melanocortin. Nat Med. 1999, 5(9):1066-1070.
26. Krude H, Biebermann H, Luck W, Horn R, Brabant G, Gruters A Severe early-onset obesity, adrenal insufficiency and red hair pigmentation caused by POMC mutations in humans. Nat Genet. 1998, 19(2):155-157.
27. Greenfield JR, Miller JW, Keogh JM, Henning E, Satterwhite JH, Cameron GS, et al. Modulation of blood pressure by central melanocortinergic pathways. N Engl J Med 2009, 360(1):44-52.
28. Nogueiras R, Wiedmer P, Perez-Tilve D, Veyrat-Durebex C, Keogh JM, Sutton GM, et al. The central melanocortin system directly controls peripheral lipid metabolism. J Clin Invest 2007, 117(11):3475-3488.
29. Rahmouni K, Fath MA, Seo S, Thedens DR, Berry CJ, Weiss R, et al. Leptin resistance contributes to obesity and hypertension in mouse models of Bardet-Biedl syndrome. J Clin Invest 2008, 118(4):1458-1467.
30. Seo S, Guo DF, Bugge K, Morgan DA, Rahmouni K, Sheffield VC Requirement of Bardet-Biedl syndrome proteins for leptin receptor signaling. Hum Mol Genet 2009, 18(7):1323-1331.
31. Collin GB, Cyr E, Bronson R, Marshall JD, Gifford EJ, Hicks W, et al. Alms1-disrupted mice recapitulate human Alstrom syndrome. Hum Mol Genet 2005, 14(16):2323-2333.
32. Longo N, Wang Y, Smith SA, Langley SD, DiMeglio LA, Giannella-Neto D Genotype-phenotype correlation in inherited severe insulin resistance. Hum Mol Genet 2002, 11(12):1465-1475.
33. Bonnefond A, Philippe J, Durand E, Muller J, Saeed S, Arslan M, et al. Highly sensitive diagnosis of 43 monogenic forms of diabetes or obesity through one-step PCR-based enrichment in combination with next-generation sequencing. Diabetes Care 2014, 37(2):460-467.
34. Willer CJ, Schmidt EM, Sengupta S, Peloso GM, Gustafsson S, Kanoni S, et al. Discovery and refinement of loci associated with lipid levels. Nat Genet 2013, 45(11):1274-1283.
35. Ehret GB, Munroe PB, Rice KM, Bochud M, Johnson AD, Chasman DI, et al. Genetic variants in novel pathways influence blood pressure and cardiovascular disease risk. Nature. 2011, 478(7367):103-109.
36. Locke AE, Kahali B, Berndt SI, Justice AE, Pers TH, Day FR, et al. Genetic studies of body mass index yield new insights for obesity biology. Nature. 2015, 518(7538):197-206.
37. Scott RA, Lagou V, Welch RP, Wheeler E, Montasser ME, Luan J, et al. Large-scale association analyses identify new loci influencing glycemic traits and provide insight into the underlying biological pathways. Nat Genet 2012, 44(9):991-1005.
38. Morris AP, Voight BF, Teslovich TM, Ferreira T, Segrè AV, Steinthorsdottir V, et al. Large-scale association analysis provides insights into the genetic architecture and pathophysiology of type 2 diabetes. Nat Genet 2012, 44(9):981-990.
39. Do R, Bailey SD, Desbiens K, Belisle A, Montpetit A, Bouchard C, et al. Genetic variants of FTO influence adiposity, insulin sensitivity, leptin levels, and resting metabolic rate in the Quebec Family Study. Diabetes 2008, 57(4):1147-1150.
40. Kraja AT, Vaidya D, Pankow JS, Goodarzi MO, Assimes TL, Kullo IJ, et al. A bivariate genome-wide approach to metabolic syndrome: STAMPEED consortium. Diabetes 2011, 60(4):1329-1339.
41. Kraja AT, Chasman DI, North KE, Reiner AP, Yanek LR, Kilpeläinen TO, et al. Pleiotropic genes for metabolic syndrome and inflammation. Mol Genet Metab 2014, 112(4):317-338.
42. Avery CL, He Q, North KE, Ambite JL, Boerwinkle E, Fornage M, et al. A phenomics-based strategy identifies loci on APOC1, BRAP, and PLCG1 associated with metabolic syndrome phenotype domains. PLoS Genet. 2011, 7(10):e1002322.
43. Zabaneh D, Balding DJ A genome-wide association study of the metabolic syndrome in Indian Asian men. PLoS One 2010, 5(8):e11961.
44. Kristiansson K, Perola M, Tikkanen E, Kettunen J, Surakka I, Havulinna AS, et al. Genome-wide screen for metabolic syndrome susceptibility Loci reveals strong lipid gene contribution but no evidence for common genetic basis for clustering of metabolic syndrome traits. Circ Cardiovasc Genet 2012, 5(2):242-249.
45. Yaghootkar H, Scott RA, White CC, Zhang W, Speliotes E, Munroe PB, et al. Genetic evidence for a normal-weight "metabolically obese" phenotype linking insulin resistance, hypertension, coronary artery disease, and type 2 diabetes. Diabetes 2014, 63(12):4369-4377.
46. Walters RG, Jacquemont S, Valsesia A, de Smith AJ, Martinet D, Andersson J, et al. A new highly penetrant form of obesity due to deletions on chromosome 16p11.2. Nature 2010, 463(7281):671-675.
47. Brown MS, Ye J, Goldstein JL Medicine. HDL miR-ed down by SREBP introns. Science 2010, 328(5985):1495-1496.
48. Dayeh T, Volkov P, Salö S, Hall E, Nilsson E, Olsson AH, et al. Genome-wide DNA methylation analysis of human pancreatic islets from type 2 diabetic and non-diabetic donors identifies candidate genes that influence insulin secretion. PLoS Genet 2014, 10(3):e1004160.
49. Johansen CT, Wang J, Lanktree MB, Cao H, McIntyre AD, Ban MR, et al. Excess of rare variants in genes identified by genome-wide association study of hypertriglyceridemia. Nat Genet 2010, 42(8):684-687.
50. Koh XH, Liu X, Teo YY Can evidence from genome-wide association studies and positive natural selection surveys be used to evaluate the thrifty gene hypothesis in East Asians?. PLoS One 2014, 9(10):e110974.